Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01387139 · ClinicalTrials.gov registry record · Phase 3

Ketamine Versus Co-administration of Ketamine and Propofol for Procedural Sedation in a Pediatric Emergency Department

A Phase 3 study, sponsored by University of Colorado, Denver.

Completed
Registry status
Phase 3
Development phase
183
Enrollment target

NCT01387139 is a Phase 3 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 183 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01387139, a Phase 3 study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
Phase 3
Development phase
183 participants
Enrollment target

Study Summary

The purpose of this study is to compare the effectiveness of the co-administration of intravenous ketamine and propofol to intravenous ketamine as a single agent for procedural sedation in the pediatric emergency department. The investigators hypothesize that patients receiving co-administration of ketamine and propofol will have a lower rate of adverse events, compared to patients receiving ketamine for procedural sedation.

Interventions

  • DRUG Ketamine
  • DRUG Ketamine Co-administered with Propofol

Trial Details

FieldValue
Enrollment Target 183 participants
Start Date 2011-01
Est. Completion 2017-11-03
Phase Phase 3

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT01387139

The ClinicalTrials.gov registry entry for NCT01387139 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.

NCT01387139 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01387139 about?

NCT01387139 is a clinical study titled "Ketamine Versus Co-administration of Ketamine and Propofol for Procedural Sedation in a Pediatric Emergency Department". The purpose of this study is to compare the effectiveness of the co-administration of intravenous ketamine and propofol to intravenous ketamine as a single agent for procedural sedation in the pediatric emergency department. The investigators hypothesize that patients receiving co-administration of ...

What is the current status of trial NCT01387139?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 183 participants. The study started on 2011-01. Estimated completion is 2017-11-03.

What interventions are being tested in trial NCT01387139?

The interventions under investigation include: Ketamine (DRUG), Ketamine Co-administered with Propofol (DRUG).

Who is sponsoring clinical trial NCT01387139?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.